Webinar | The Do’s and Don’ts of Managing a Pivotal Gene Therapy Trial
Date: Tuesday, January 28, 2020
Time: 2:00pm EST
Duration: 1 hour
About the Webinar:
Gene therapies have been exploding in popularity, with big and small players lining up scores of new programs looking to create entirely new standard of care models for a wide variety of diseases. But what does it take to de-risk a pivotal, registration-worthy gene therapy program? What are the pitfalls to avoid and the opportunities in creating more efficient designs that are more likely to get a nod from regulators?
Join Deborah Wild, Chief of Staff and VP of Corporate Development at Catalent, Kathy Reape, Chief Medical Officer at Spark Therapeutics, and Endpoints News editor John Carroll as they discuss this and more during an upcoming webinar.
Chief of Staff & VP of Corporate Development, Catalent
Chief Medical Officer, Spark Therapeutics
Founders & Editor, Endpoints News